Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Karynsa Cetin"'
Autor:
Karynsa Cetin, Bhakti Mehta, Carla Bezold, Jeffrey S. Wasser, Fiona Callaghan, Lauren C. Bylsma, Jon P. Fryzek
Publikováno v:
American Journal of Hematology
Immune thrombocytopenia (ITP) is a rare platelet disorder that is often persistent or chronic in adults. Patient management is dependent upon physician judgment and patient preference, given both the rarity of the condition and a paucity of high‐qu
Autor:
Diane Reams, Rohini K. Hernandez, Karynsa Cetin, Leah J. McGrath, Alexander Liede, M Alan Brookhart, Robert A. Overman, Steven A. Narod
Publikováno v:
Clinical Epidemiology
Leah J McGrath,1 Robert A Overman,1 Diane Reams,1 Karynsa Cetin,2 Alexander Liede,3 Steven A Narod,4 M Alan Brookhart,1 Rohini K Hernandez2 1NoviSci, LLC, Durham, NC, USA; 2Amgen Inc, Thousand Oaks, CA, USA; 3Amgen Inc, South San Franscisco, CA, USA;
Autor:
Karynsa Cetin, B. Diane Reams, Rohini K. Hernandez, Anne M. Butler, Amy P. Abernethy, Alexander Liede, Robert A. Overman, Jung In Kim, Bradford R. Hirsch, M. Alan Brookhart
Publikováno v:
Pharmacoepidemiology and Drug Safety. 27:229-238
Purpose To examine the dynamics of treatment with 2 bone-targeting agents (BTAs)-denosumab and zoledronic acid-among men with bone metastases from prostate cancer. Methods Using electronic health record data from oncology practices across the US, we
Publikováno v:
Rare Tumors, Vol 1, Iss 2, Pp e52-e52 (2009)
Malignant giant cell tumor (GCT) of bone is a rare tumor with debilitating consequences. Patients with GCT of bone typically present with mechanical difficulty and pain as a result of bone destruction and are at an increased risk for fracture. Becaus
Externí odkaz:
https://doaj.org/article/33e8995a6a4141e6aada769610ee0afc
Publikováno v:
Current Medical Research and Opinion. 34:209-216
Objective: Immune thrombocytopenia (ITP) is characterized by low platelet counts and a tendency toward increased bleeding and bruising. We aimed to describe bleeding frequency and use of rescue ITP therapy to treat or prevent bleeding in elderly ITP
Autor:
Kelly, Fust, Anju, Parthan, Xiaoyan, Li, Anjali, Sharma, Xinke, Zhang, Marco, Campioni, Junji, Lin, Xuena, Wang, Richard, Zur, Karynsa, Cetin, Melissa, Eisen, David, Chandler
Publikováno v:
The American journal of managed care. 24(8 Spec)
This analysis estimated the cost per response and the incremental cost per additional responder of romplostim, eltrombopag, and the "watch-and-rescue" (monitoring until rescue therapies are required) strategy in adults with chronic immune thrombocyto
Publikováno v:
Urology. 81:1184-1189
Objective To provide the first comprehensive assessment of the number of men exposed to continuous androgen deprivation therapy (ADT) in the nonmetastatic setting in the United States. Methods We assembled 2 point-prevalent cohorts on December 31, 20
Autor:
Karynsa Cetin, Junji Lin, David Chandler, Xinke Zhang, Jeffrey S. Wasser, Ivy Altomare, Xiaoyan Li
Publikováno v:
Clinical therapeutics. 39(3)
We estimated the real-world costs of bleeding-related episodes (BREs) in adults with primary immune thrombocytopenia (ITP).This retrospective cohort study used the MarketScan Commercial Claims and Encounters and Medicare Supplemental and Coordination
Autor:
Kendra Schwartz, Karynsa Cetin, Vahakn B. Shahinian, Cecilia Yee, John F. Acquavella, Jennifer L. Beebe-Dimmer, Hal Morgenstern
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:70-78
Purpose Fractures are a recognized consequence of androgen deprivation therapy (ADT); however, less is known about the incidence of fracture in relation to the timing of ADT use or the impact of fracture on mortality in men with prostate cancer. Meth
Autor:
Leah J. McGrath, Diane Reams, Karynsa Cetin, Robert A. Overman, M Alan Brookhart, Jeffrey S. Wasser, Anjali Sharma, Ivy Altomare
Publikováno v:
Blood. 132:497-497
Introduction: Immune thrombocytopenia (ITP) is a rare platelet disorder that can lead to an increased tendency to bleed. Recommended first-line therapies include corticosteroids, intravenous immunoglobulin (IVIg) and intravenous (IV) anti-D. An estim